It was proposed that miR-185 inhibits activation of HSCs and prevents liver fibrosis via targeting the Ras homolog enriched in brain (RHEB) and the rapamycin-insensitive companion of mammalian target of rapamycin (RICTOR)32. The gene discussed is RHEB; the disease is Hepatic fibrosis.